IDEAS home Printed from https://ideas.repec.org/a/plo/pgph00/0003241.html
   My bibliography  Save this article

Strengthening regulation for medical products in Tanzania: An assessment of regulatory capacity development, 1978–2020

Author

Listed:
  • Adam M Fimbo
  • Hiiti B Sillo
  • Alex Nkayamba
  • Sunday Kisoma
  • Yonah Hebron Mwalwisi
  • Rafiu Idris
  • Sarah Asiimwe
  • Patrick Githendu
  • Osondu Ogbuoji
  • Linden Morrison
  • Jesse B Bump
  • Eliangiringa Kaale

Abstract

Improving medicines regulation can lead to better population health, but how this process works in low- and middle-income countries remains underexplored. Tanzania’s pharmaceutical sector is often cited as a successful example of a well-functioning regulatory system in a developing country, attributed to the work of the Tanzania Food and Drugs Authority (TFDA), now the Tanzania Medicines and Medical Devices Authority (TMDA). This raises the question: how was this regulatory capacity developed, and what lessons can other countries learn from Tanzania’s experience? This paper analyzes changes in Tanzania’s pharmaceutical regulation over three periods of significant sectoral reform. A desk review was conducted of Tanzania’s policies, laws, regulations, guidelines, procedures, and institutional reports. The study reveals that Tanzania’s regulatory capacity improved significantly through targeted reforms that addressed challenges in key regulatory areas. The three key periods examined are: 1) The separation of medicines regulation from food safety (1978–2003), 2) The expansion of regulatory domains and the establishment of a semi-autonomous regulatory agency (2003–2011), and 3) The expanded role of the Pharmacy Council to include premises regulation (2011–2020). The development of a well-functioning regulatory system in Tanzania resulted from advancements in four key areas: 1) The evolution of a legal regulatory framework, 2) Strong stakeholder engagement, 3) Continuous capacity building, and 4) Effective organizational leadership. Tanzania’s regulatory system has evolved from being relatively ineffective to leading regional harmonization efforts in East Africa. This progress was not linear, requiring sustained effort, collaboration, and support from key development partners such as the Global Fund, WHO, and UNDP. Future efforts to enhance regulatory effectiveness should focus on creating adaptive systems that respond to changing needs, rather than solely prescriptive functions.

Suggested Citation

  • Adam M Fimbo & Hiiti B Sillo & Alex Nkayamba & Sunday Kisoma & Yonah Hebron Mwalwisi & Rafiu Idris & Sarah Asiimwe & Patrick Githendu & Osondu Ogbuoji & Linden Morrison & Jesse B Bump & Eliangiringa K, 2024. "Strengthening regulation for medical products in Tanzania: An assessment of regulatory capacity development, 1978–2020," PLOS Global Public Health, Public Library of Science, vol. 4(10), pages 1-29, October.
  • Handle: RePEc:plo:pgph00:0003241
    DOI: 10.1371/journal.pgph.0003241
    as

    Download full text from publisher

    File URL: https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0003241
    Download Restriction: no

    File URL: https://journals.plos.org/globalpublichealth/article/file?id=10.1371/journal.pgph.0003241&type=printable
    Download Restriction: no

    File URL: https://libkey.io/10.1371/journal.pgph.0003241?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Jillian Clare Cohen & James A. Cercone & Roman Macaya, 2002. "Improving Transparency in Pharmaceutical Systems : Strengthening Critical Decision Points Against Corruption," World Bank Publications - Reports 20426, The World Bank Group.
    2. Martha Embrey & Catherine Vialle-Valentin & Angel Dillip & Bernard Kihiyo & Romuald Mbwasi & Innocent A Semali & John C Chalker & Jafary Liana & Rachel Lieber & Keith Johnson & Edmund Rutta & Suleiman, 2016. "Understanding the Role of Accredited Drug Dispensing Outlets in Tanzania’s Health System," PLOS ONE, Public Library of Science, vol. 11(11), pages 1-16, November.
    3. Risha, Peter Gasper & Msuya, Zera & Clark, Malcolm & Johnson, Keith & Ndomondo-Sigonda, Margareth & Layloff, Thomas, 2008. "The use of Minilabs® to improve the testing capacity of regulatory authorities in resource limited settings: Tanzanian experience," Health Policy, Elsevier, vol. 87(2), pages 217-222, August.
    4. Kaplan, Warren A. & Ritz, Lindsay Sarah & Vitello, Marie & Wirtz, Veronika J., 2012. "Policies to promote use of generic medicines in low and middle income countries: A review of published literature, 2000–2010," Health Policy, Elsevier, vol. 106(3), pages 211-224.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Sabine Vogler & Valérie Paris & Alessandra Ferrario & Veronika J. Wirtz & Kees Joncheere & Peter Schneider & Hanne Bak Pedersen & Guillaume Dedet & Zaheer-Ud-Din Babar, 2017. "How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries," Applied Health Economics and Health Policy, Springer, vol. 15(3), pages 307-321, June.
    2. Lins Ferreira, Vinicius & Pereira da Veiga, Cássia Rita & Kudlawicz-Franco, Claudineia & Scalercio, Priscila & Ramires, Yohanna & Pontarolo, Roberto & Carvalho, Denise Maria W. & da Veiga, Claudimar , 2017. "Generic drugs in times of economic crisis: Are there changes in consumer purchase intention?," Journal of Retailing and Consumer Services, Elsevier, vol. 37(C), pages 1-7.
    3. Dai, Rong & Watal, Jayashree, 2021. "Product patents and access to innovative medicines," Social Science & Medicine, Elsevier, vol. 291(C).
    4. Mirza Lalani & Scott Kaba Matafwali & Aminata Dior Ndiaye & Jayne Webster & Sian E Clarke & Harparkash Kaur, 2023. "An absence of evidence breeds contempt: A qualitative study of health system stakeholder perceptions of the quality of medicines available in Senegal," PLOS Global Public Health, Public Library of Science, vol. 3(7), pages 1-12, July.
    5. Marlène Guillon & Josselin Thuilliez, 2015. "HIV and Rational risky behaviors: a systematic review of published empirical literature (1990-2013)," Documents de travail du Centre d'Economie de la Sorbonne 15065, Université Panthéon-Sorbonne (Paris 1), Centre d'Economie de la Sorbonne.
    6. Omar Galárraga & Veronika J Wirtz & Yared Santa-Ana-Tellez & Eline L Korenromp, 2013. "Financing HIV Programming: How Much Should Low- And Middle-Income Countries and their Donors Pay?," PLOS ONE, Public Library of Science, vol. 8(7), pages 1-11, July.
    7. repec:hal:wpaper:halshs-01222571 is not listed on IDEAS
    8. Warren A Kaplan & Veronika J Wirtz & Peter Stephens, 2013. "The Market Dynamics of Generic Medicines in the Private Sector of 19 Low and Middle Income Countries between 2001 and 2011: A Descriptive Time Series Analysis," PLOS ONE, Public Library of Science, vol. 8(9), pages 1-11, September.
    9. Yanqi Wu & Jie Chen & Hui Fang & Yuehua Wan, 2020. "Intimate Partner Violence: A Bibliometric Review of Literature," IJERPH, MDPI, vol. 17(15), pages 1-17, August.
    10. Katrina Perehudoff & Ivan Demchenko & Nikita V. Alexandrov & David Brutsaert & Angela Ackon & Carlos E. Durán & Faris El-Dahiyat & Firdaus Hafidz & Rezwan Haque & Rabia Hussain & Roderick Salenga & Fa, 2020. "Essential Medicines in Universal Health Coverage: A Scoping Review of Public Health Law Interventions and How They Are Measured in Five Middle-Income Countries," IJERPH, MDPI, vol. 17(24), pages 1-30, December.
    11. Mingyue Zhao & Lingyi Zhang & Zhitong Feng & Yu Fang, 2021. "Physicians’ Knowledge, Attitude and Practice of Generic Substitution in China: A Cross-Sectional Online Survey," IJERPH, MDPI, vol. 18(15), pages 1-13, July.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pgph00:0003241. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: globalpubhealth (email available below). General contact details of provider: https://journals.plos.org/globalpublichealth .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.